Carregant...
Survival analysis of immune-related lncRNA in low-grade glioma
BACKGROUND: Low-grade glioma is grade I-II glioma. Immunotherapy is a promising way of tumor killing. Research on immune molecular mechanisms in low-grade gliomas and discovery of new immune checkpoints for low-grade gliomas are of great importance. METHODS: Gene sequencing data and clinical data of...
Guardat en:
| Publicat a: | BMC Cancer |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6697914/ https://ncbi.nlm.nih.gov/pubmed/31419958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6032-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|